期刊文献+

适形调强放疗对鼻咽癌患者视神经功能影响的剂量分析和临床初步结果 被引量:2

The Dose Analysis and Preliminary Clinical Outcomes on Optic Nerve Function after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma Patients
下载PDF
导出
摘要 背景与目的:鼻咽癌放疗后视神经的损伤越来越受到重视,适形调强放疗(IMRT)作为一种精确放疗技术,对视神经保护具有一定的优势,但缺乏相关临床数据。本研究通过对鼻咽癌患者放疗计划剂量和临床结果分析,了解IMRT对视神经保护的作用。方法:9例初治鼻咽癌男性患者于2007年12月至2008年12月接受了适形调强放疗,其中T2 3例,T3 6例。由IMRT计划系统得到视神经受照剂量及视神经与鼻咽肿瘤的距离,并于放疗前和放疗后6个月检测患者双侧视神经的视力、视野和视诱发电位。结果:9例患者均无视神经功能损伤的表现,视神经剂量受肿瘤生长的部位影响,视神经与肿瘤的最短距离和视神经最大剂量呈显著负相关(r=-0.912,P<0.001)。结论:IMRT技术可以较好地保护鼻咽癌患者的视神经功能,视神经与肿瘤的最短距离是视神经剂量的决定因素。 BACKGROUND OBJECTIVE: More and more attentions are paid to the optic nerve damage in nasopharyngeal carcinoma(NPC) patients after radiotherapy.As an precise irradiation technology,intensity-modulated radiotherapy(IMRT) has certain advantages to protect the optic nerve,but there is relative lack of clinical data.In this study,we investigated the radiotherapy planned dose and clinical results of nasopharyngeal carcinoma patients.We explored the value of IMRT in optic nerve protection.METHODS: Nine male patients with primary nasopharyngeal carcinoma received IMRT between Dec.2007 and Dec.2008.According to 2002 UICC/AJCC staging system,3 patients were staged as T2 and 6 as T3.The delivered dose to optic nerves and the shortest distance from optic nerve to tumor were calculated with IMRT planning system.The eyesight,visual field and visual evoked potential(VEP)were detected before IMRT and six months after IMRT.RESULTS:All patients are alive by the end of June 2011,and there were no radiation optic neuropathy(RON).The dose delivered to optic nerves is influenced by the tumor locations.The maximal doses of optic nerves is significantly correlated with the shortest distance from nerve to tumor(r=0.912,P0.001).CONCLUSONS:IMRT techniques could preferably protect the optic nerve function in NPC patients.The shortest distance from nerve to tumor is a determining factor to the received dose of the optic nerves.
出处 《中国神经肿瘤杂志》 2011年第3期171-175,共5页 Chinese Journal of Neuro-Oncology
基金 广东省医学科学基金项目资助(NoA20080219)
关键词 适形调强放射治疗 放射性视神经病变 鼻咽癌 IMRT Radiation optic neuropathy Nasopharyngeal neoplasm
  • 相关文献

参考文献15

二级参考文献51

  • 1赵充.鼻咽癌调强适形放疗进展[J].实用肿瘤杂志,2004,19(4):281-284. 被引量:39
  • 2[1]Lee AW, Law SC, Foo W, et al. Nasopharyngeal carcinoma:Local control by megavoltage irradiation [J]. Br J Radiol, 1993,66:528 - 536.
  • 3[2]Perez CA, Devineni VR, Marcial-Vega V, et al. Carcinoma of the nasopharynx: Factors affecting prognosis [J]. Int J Radiat Oncol Biol Phys, 1992, 23:271 -280.
  • 4[3]Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control [J]. Int J Radiat Oncol Biol Phys, 1997,37:985 - 996.
  • 5[4]Kutcher GJ, Fuks Z, Brenner H, et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx [J].Int J Radiat Oncol Biol Phys, 1991,21:169 - 182.
  • 6[5]Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx [J]. Int J Radiat Oncol Biol Phys, 1991, 20:823 -833.
  • 7[6]Cooper JS, del Rowe J, Newall J. Regional Stage Ⅳ carcinoma of the nasopharynx treated by aggressive radiotherapy [J]. Int J Radiat Oncol Biol Phys, 1983, 9:1737 - 1745.
  • 8[7]Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer [J]. Int J Radiat Oncol Biol Phys, 2001,49:623 - 632.
  • 9[8]Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for Nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys, 2000, 48:329 -337.
  • 10[10]Butler EB, Teh BS, Grant WH, et al. SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy [J]. Int J Radtat Oncol Biol Phys, 1999, 45:21 - 32.

共引文献114

同被引文献43

  • 1Ann Dorothy King,Kunwar Suryaveer Singh Bhatia.Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck[J].World Journal of Radiology,2010,2(5):159-165. 被引量:25
  • 2张庆平,阮林,谢成熹,黄光武,周卫为.鼻咽癌放疗后视觉通路损伤相关因素的分析[J].临床神经病学杂志,2006,19(3):176-178. 被引量:4
  • 3Trotti A, Colevas AD, Setser A, et al. CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment [ J ]. Semin Radiat Oncol,2003,13 (3) : 176 - 181.
  • 4Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) [ J ]. J Natl Cancer Inst, 2014,106 (9):1 -11.
  • 5Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy[ J]. Int J Radiat Oncol Biol Phys, 2000,47 (1) :13 -47.
  • 6Cacciatore F, Napoli C, Abete P, et al. Quality of life determinants and hearing function in an elderly population: Osservatorio Geriatrico Campano Study Group [J]. Gerontology, 1999,45 (6) :323 - 328.
  • 7Wang SZ, Wang WF, Zhang HY, et al. Analysis of anatomical factors controlling the morbidity of radiation- induced otitis media with effusion [ J ]. Radiother Oncol, 2007,85(3) :463 -468.
  • 8Mujica-Mota MA, Ibrahim FF, Bezdjian A, et al. The effect of fractionated radiotherapy in sensorineural hearing loss : an animal model [ J ]. Laryngoscope, 2014, 124 (10) :E418 - E424.
  • 9Gibb AG, Loh KS. The role of radiation in delayed hearing loss in nasopharyngeal carcinoma[ J]. J Laryngol Otol,2000,114(2) :139 - 144.
  • 10Herrmann F, Dorr W, Muller R, et al. A prospective study on radiation-induced changes in hearing function [ J ]. Int J Radiat Oncol Biol Phys,2006,65 (5) :1338 - 1344.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部